Blogs
Welcome to Unibest's Blogs section! Here, you will find valuable insights and in-depth reports covering various topics related to drugs and diseases. Our blogs aim to provide an enhanced understanding of the clinical significance and breakthroughs your clients can make. Stay updated with the latest trends, technological advancements, and industry analyses as we dive deep into the world of pharmaceuticals, giving you the knowledge and resources you need to stay ahead of the competition.

Ketorolac Tromethamine

If you want to know more about the Ketorolac Tromethamine, the following articles will give you some help. These news is the latest market situation, trend in development, or related tips of the Ketorolac Tromethamine industry. More news about Ketorolac Tromethamine, are being released. Follow us / contact us for more Ketorolac Tromethamine information!
  • Drug Patent & Exclusivity Expiration Report - Week of Nov 25 2024

    Drug Patent & Exclusivity Expiration Report - Week of Nov 25 2024

    2024-11-25

    This week, there are 3 drugs in the patent and exclusivity list. They are: - ABBVIE INC's ACULAR LS, containing active ingredient KETOROLAC TROMETHAMINE - FRESENIUS KABI USA LLC's DIPRIVAN, containing active ingredient PROPOFOL - GLOBAL BLOOD THERAPEUTICS INC's OXBRYTA, containing active ingredient VOXELOTOR Read More